These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1600054)

  • 1. Night-time or morning dosing with H2-receptor antagonists: studies on acid inhibition in normal subjects.
    Patel N; Ward U; Rogers MJ; Primrose JN
    Aliment Pharmacol Ther; 1992 Jun; 6(3):381-7. PubMed ID: 1600054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
    Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of 300 mg ranitidine at night, twice daily and four times daily on intragastric acidity in normal subjects.
    Primrose JN; Rogers MJ; Holmfield JH
    Aliment Pharmacol Ther; 1993 Jun; 7(3):287-91. PubMed ID: 8364134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.
    Prewett EJ; Hudson M; Nwokolo CU; Sawyerr AM; Pounder RE
    Gastroenterology; 1991 Apr; 100(4):873-7. PubMed ID: 2001826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose treatment with H2 receptor antagonists: is bedtime administration too late?
    Merki H; Witzel L; Harre K; Scheurle E; Neumann J; Röhmel J
    Gut; 1987 Apr; 28(4):451-4. PubMed ID: 3583073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
    Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
    Bianchi Porro G; Parente F; Sangaletti O
    Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 800 mg cimetidine once daily on gastric acid secretion.
    Dammann HG; Walter TA; Mueller P; Simon B
    Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
    Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
    Hamilton MI; Sercombe J; Pounder RE
    Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.